Author

Thomas Melendy

Roswell Park Comprehensive Cancer CenterORCID 0000-0003-1558-6262Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrei V. BakiniD· 1 shared Barbara A. FosteriD· 1 shared Christos K FountzilasiD· 1 shared Henry G. WithersiD· 1 shared Jun QuiD· 1 shared Justin ZonnevilleiD· 1 shared Mohammed AlruwailiiD· 1 shared Priyanka RajaniD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andrei V. BakinORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 6, 2025

A Sequential Triple-Drug Strategy for Selective Targeting of p53-Mutant Cancers

Mohammed Alruwaili, Yanqi Guo, Justin Zonneville…·Andrei V. Bakin

This paper develops a sequential triple-drug strategy targeting p53 mutant cancers, showing it effectively induces cell death while minimizing toxicity to normal cells.

DOI 10.1101/2025.11.06.687028

humanexperimental assay

𝕏 PostBluesky

MicrobiologyInternational Journal of Molecular SciencesPeer-reviewedApr 21, 2024

Proteomics analysis reveals novel phosphorylated residues and associated proteins of the polyomavirus DNA replication initiation complex.

Rama Dey-Rao, Shichen Shen, Jun Qu, Thomas Melendy

5 citations

proteomicsexperimental assay

𝕏 PostBluesky